Left atrial function index predicts poor outcomes in acute myocardial infarction patients treated with percutaneous

Yijin Tang1, Siling Peng1, Hui-Ling Yao2

  • 1Department of Cardiology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China.

PubMed

Insights

The left atrial function index (LAFI) can predict adverse events in acute myocardial infarction (AMI) patients undergoing percutaneous coronary intervention (PCI). Lower LAFI values indicate a higher risk of adverse cardiovascular events, aiding in patient risk stratification.

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiovascular Research

Background:

  • The prognostic significance of the left atrial function index (LAFI) in acute myocardial infarction (AMI) patients treated with percutaneous coronary intervention (PCI) remains unclear.
  • LAFI integrates left atrial emptying fraction, adjusted left atrial volume, and stroke volume.

Purpose of the Study:

  • To investigate the predictive value of LAFI for prognosis in patients with AMI who have undergone PCI.
  • To determine if LAFI can be utilized for risk stratification in this patient population.

Main Methods:

  • Prospective enrollment of 368 AMI patients treated with PCI.
  • Transthoracic echocardiography (TTE) performed at baseline and follow-up.
  • Endpoint events included rehospitalization for unstable angina, nonfatal myocardial infarction, heart failure, and cardiovascular death.

Main Results:

  • Patients experiencing endpoint events had significantly lower LAFI compared to those without events (34.25 ± 12.86 vs. 48.38 ± 19.42, P < 0.0001).
  • Multivariate Cox analysis identified LAFI (HR=0.97; P=0.012) and Killip classification (HR=1.51; P=0.034) as independent predictors of adverse events.
  • Kaplan-Meier analysis showed significantly higher event rates in patients with LAFI ≤ 40.17 cm/ml/m² (HR=8.53; P < 0.0001).

Conclusions:

  • The left atrial function index (LAFI) is a robust and independent predictor of adverse cardiovascular events in AMI patients treated with PCI.
  • LAFI can be effectively used for risk stratification in this patient cohort, guiding clinical management.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30